FMR LLC
- SEC CIK
- 0000315066
- Latest filing
- Aug 13, 2026
ALGS holding history
Aligos Therapeutics, Inc. in every 13F filed by FMR LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ALGS overviewAll 13F holders of ALGSFull Q2 2026 holdings
- Shares (Q2 2026)
- 10
- Value
- $58
- % of portfolio
- <0.1%
- Quarters held
- 10
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 10 | $58 | <0.1% | +10 | New | Holders |
| Q1 2026 | 0 | $0 | 0.0% | −4,972−100.0% | Sold out | Holders |
| Q4 2025 | 4,972 | $46.3K | <0.1% | +4,972 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −10−100.0% | Sold out | Holders |
| Q2 2025 | 10 | $72 | <0.1% | +10 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −1,200−100.0% | Sold out | Holders |
| Q3 2023 | 1,200 | $896 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 1,200 | $1.17K | <0.1% | +200+20.0% | Added | Holders |
| Q1 2023 | 1,000 | $874 | <0.1% | −12−1.2% | Reduced | Holders |
| Q4 2022 | 1,012 | $964 | <0.1% | −1−0.1% | Reduced | Holders |
| Q3 2022 | 1,013 | $1.00K | <0.1% | +532+110.6% | Added | Holders |
| Q2 2022 | 481 | $1.00K | <0.1% | −4,966−91.2% | Reduced | Holders |
| Q1 2022 | 5,447 | $12.0K | <0.1% | +5,447 | New | Holders |